Something to Be Done: Treating HIV/AIDS

Author:

Bloom David E.1,Associates River Path2

Affiliation:

1. Department of Population and International Health, School of Public Health, Harvard University, Boston, MA 02115, USA.

2. 61a West Borough, Wimborne, Dorset BH 21 1LX, UK.

Abstract

Largely because of disparities in access to drug treatment and care, AIDS morbidity and mortality have fallen in the developed world but continue to rise among developing countries. Achieving more equitable access to AIDS drugs is hindered by high drug prices, technical complexities related to the provision of health care, and conflict among stakeholders. Recognition that health is vital to the prospects of the emerging global society must be combined with new mechanisms to help all stakeholders work together cooperatively. Tiered drugs pricing should be coupled with investment in health services. An independent “Global Task Force,” able to act as an “active think tank,” could build consensus about the way forward.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference33 articles.

1. Ninety-five percent of HIV-positive people live in developing countries. Furthermore our analysis shows a correlation of 0.49 across 51 countries with the requisite data between the absolute poverty rate in 1990 (the percentage of population living on less than $1 per day) and the adult HIV prevalence in 1997.

2. M. Schoofs “Part 8: Use What You Have ” in the series “AIDS: The Agony of Africa ” Village Voice 29 December 1999 (available at ).

3. Enhancing Care Initiative “AIDS Care Framework” (available at ).

4. For a complete list see FDA “Approved Drugs for HIV/AIDS or AIDS-Related Conditions ” last updated 6 July 1999 (available at ); “Antiretroviral Drugs Approved by FDA for HIV ” last updated 2 March 2000 (available at ).

5. See also D. E. Bloom and River Path Associates “Social Capitalism and Human Diversity” (The Creative Society of the 21st Century Organisation for Economic Co-operation and Development Paris in press).

Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3